Advances in Charcot-Marie-Tooth disease research: cellular function of CMT-related proteins, transgenic animal models, and pathomechanisms. The European CMT Consortium.
The First Workshop of the European Consortium on Charcot-Marie-Tooth (CMT) disease brought together neuroscientists, molecular and cell biologists, neuropathologists, neurologists, and geneticists with a common interest in the understanding of the fundamental mechanisms that underlie the pathogenesis of CMT. The interdisciplinary group of 25 expert scientists discussed recent advances in (i) molecular genetics and histopathology of CMT, (ii) development of suitable animal models, (iii) understanding of the cellular function of CMT-related proteins, and (iv) studies using nerve biopsies from CMT patients. In this minireview, we summarize the key findings presented and discuss their impact on CMT research.
Müller
H W
HW
Department of Neurology, Heinrich-Heine-University, Düsseldorf, Germany. mueller@neurologie.uni-duesseldorf.de
Suter
U
U
Van Broeckhoven
C
C
Hanemann
C O
CO
Nelis
E
E
Timmerman
V
V
Sancho
S
S
Barrio
L
L
Bolhuis
P
P
Dermietzel
R
R
Frank
M
M
Gabreëls-Festen
A
A
Gillen
C
C
Haites
N
N
Levi
G
G
Mariman
E
E
Martini
R
R
Nave
K
K
Rautenstrauss
B
B
Schachner
M
M
Schenone
A
A
Schneider
C
C
Schröder
M
M
Willecke
K
K
Haneman
O
O
D000818:Animals; D030801:Animals, Genetically Modified / Q000502:physiology; D002607:Charcot-Marie-Tooth Disease / Q000473:pathology / Q000503:physiopathology*; D004195:Disease Models, Animal; D006801:Humans; D009419:Nerve Tissue Proteins / Q000502:physiology; D009462:Neurology / Q000639:trends*; D012106:Research
D009419:Nerve Tissue Proteins